J.P. Morgan Sticks to Its Hold Rating for Revvity (RVTY)
I'm PortAI, I can summarize articles.
Vatnsdal covers the Healthcare sector, focusing on stocks such as Bruker, Agilent, and DENTSPLY SIRONA. According to TipRanks, Vatnsdal has an average return of 2.7% and a 45.57% success rate on recommended stocks. In addition to J.P. Morgan, Revvity also received a Hold from TR | OpenAI – 4o’s Cira Diagnissa in a report issued on October 2. However, on October 7, Evercore ISI maintained a Buy rating on Revvity (NYSE: RVTY).
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments